Dossier assessment

Dabrafenib - Benefit assessment according to § 35a Social Code Book V (dossier assessment)

Status
Status: Commission completed
Project no.
A13-35
Last updated

Report documents

  1. Extract of dossier assessment

    Dabrafenib - Benefit assessment according to § 35a Social Code Book V (dossier assessment)

    published on
    Document type
    PDF document, 315 kB, EN, not accessible
  2. Dossier assessment

    Dabrafenib - Benefit assessment according to § 35a Social Code Book V (dossier assessment)

    published on
    Document type
    PDF document, 690 kB, DE, not accessible

Press releases

Dabrafenib: also no added benefit over vemurafenib

Results from indirect comparison did not allow any reliable conclusions

Dabrafenib in melanoma: added benefit not proven

No differences could be shown for mortality, symptoms and quality of life / concerning side effects, data too uncertain

Project details

Project no.
A13-35
Commission
Commission awarded on 24.09.2013 by the Federal Joint Committee (GBA).
Report type
Dossier assessment
Status
Commission completed
Department/Division
Drug Assessment
Topic
Cancer
Note

After completion of the assessment by IQWiG the Federal Joint Committee (G-BA) conducts a commenting procedure. This may provide supplementary information and as a result lead to a modified benefit assessment. Further information and the decision on the early benefit assessment can be found on the relevant page of the G-BA website.

Connected Projects

  1. Dossier assessment

    Dabrafenib (melanoma) - Benefit assessment according to §35a Social Code Book V

    Project no.
    A18-59
    Last updated

    Status: Commission completed

  2. Dossier assessment

    Dabrafenib (non-small cell lung cancer) - Benefit assessment according to §35a Social Code Book V

    Project no.
    A17-17
    Last updated

    Status: Commission completed

  3. Dossier assessment

    Dabrafenib (new therapeutic indication) - Benefit assessment according to §35a Social Code Book V

    Project no.
    A15-39
    Last updated

    Status: Commission completed

  4. Addendum

    Addendum to Commission A13-35 (dabrafenib)

    Project no.
    A14-10
    Last updated

    Status: Commission completed

Contact

Info Service (German)

Subscribe to daily updated information on projects, calls for tender, current vacancies and events as well as our press releases.

Register

Contact form

Questions about commissions, publications and press releases can be sent to us via this form.

Contact form